CAS: 1627091-47-7
MLi-2
CAS:1627091-47-7
MLi-2: Novel, potent CNS-active LRRK2 inhibitor; IC50s: 0.76nM in vitro, 1.4nM cellular, 3.4nM binding.
Formula:
C21H25N5O2
Purity:
98.96%
Color and Shape:
Solid
Molecular weight:
379.46
Ref: TM-T16115
| 1mg | 66.00 € | ||
| 2mg | 96.00 € | ||
| 5mg | 133.00 € | ||
| 10mg | 197.00 € | ||
| 25mg | 435.00 € | ||
| 50mg | 658.00 € | ||
| 100mg | 937.00 € | ||
| 1mL*10mM (DMSO) | 142.00 € |
Estimated delivery in United States, on Monday 5 May 2025
MLi-2 - Bio-X
CAS:1627091-47-7
Formula:
C21H25N5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
379.4555
Ref: IN-DA01E6U7
| 1mg | 54.00 € | ||
| 2mg | 63.00 € | ||
| 25mg | 202.00 € | ||
| 50mg | 246.00 € | ||
| 100mg | 649.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Monday 5 May 2025
Rel-(2S,6R)-2,6-Dimethyl-4-(6-(5-(1-Methylcyclopropoxy)-1H-Indazol-3-Yl)Pyrimidin-4-Yl)Morpholine
CAS:1627091-47-7
Purity:
98%
Molecular weight:
379.46g/mol
Ref: 54-OR1023326
| 100mg | 461.00 € | ||
| 250mg | 769.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
Ref: 54-BUP05424
| 25mg | 650.00 € | ||
| 50mg | 966.00 € | ||
| 100mg | 1,268.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
MLi-2
CAS:1627091-47-7
A brain-penetrant inhibitor of leucin-rich repeat kinase 2 (LRRK2) with IC50 = 0.76 nM and …
Formula:
C21H25N5O2
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
379.46 g/mol
Ref: 3D-FD157083
| 2mg | 192.00 € | ||
| 5mg | 345.00 € | ||
| 10mg | 468.00 € | ||
| 25mg | 971.00 € | ||
| 50mg | 1,673.00 € |
Estimated delivery in United States, on Friday 16 May 2025
MLi-2
Controlled ProductCAS:1627091-47-7
Formula:
C21H25N5O2
Color and Shape:
Neat
Molecular weight:
379.455
Ref: TR-M425473
| 25mg | 21,891.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
